Zantac Users Should Hold On To or Mail Back Unused Portions Instead Of Physically Returning The Drug

During the COVID19 pandemic, the US Food and Drug Administration Recommends that Zantac patients do not physically return unused portions of the drug unless deemed safe to do so by state officials

Monday, April 20, 2020 - Individuals that are using Zantac and others over the counter and have unused portions are urged to continue to follow the directions of their state and local health authorities and not physically take the drug back to the retailer. Instead, follow the instructions on the Zantac.com website and the product's packaging. Due to the COVID-19 pandemic, "The FDA recommends patients and consumers not take their medicines to a drug take-back location but follow the specific disposal instructions in the medication guide or package insert or follow the agency's recommended steps, which include ways to safely dispose of these medications at home," according to federal government health officials. Zantac antacid cancer lawsuit attorneys offer a no obligation free consultation and represent Americans nationwide.

The US Food and Drug Administration has requested that Sanofi immediately recall all over the counter and prescription packages of anti-heartburn and acid reflux medication under the brand name of Zantac and to halt manufacturing or selling the drug. According to the FDA, "All ranitidine products, including the oral liquid/syrup, will be withdrawn by their manufacturers and will not be available on the U.S. market. This action differs from past actions because this is the first time the FDA is requesting market withdrawal of all ranitidine products." The US drug watchdog agency has found excessively high levels of N-nitrosodimethylamine (NDMA), a naturally occurring carcinogen given to laboratory test animals to induce cancer tumors for research, some as high as 30,000 nanograms per tablet due to NDMA increase over time and in higher temperature environments and that the drug presents a cancer risk to consumers. Men and women that have taken Zantac for decades and have developed stomach, bladder, esophageal, prostate and other cancers have consulted with Zantac cancer lawyers and have filed suit seeking real monetary damages.

In the wake of the FDA recall of Zantac and other heartburn and acid reflux drugs that may cause cancer, there are a host of other antacids that have not tested positive for the carcinogen and that the FDA currently considered safe. As of the time of this writing, the FDA has not found NDMA in famotidine (Pepcid), cimetidine (Tagamet), esomeprazole (Nexium), lansoprazole (Prevacid) or omeprazole (Prilosec). One should ask their physician for a recommendation based on their medical condition and history. In addition to Zantac, the FDA has recalled all ranitidine products from the U.S. market. Zantac patients should stop taking the drug and dispose of any unused portions of the product. Patients with severe heartburn or acid reflux may continue taking the medication provided they immediately consult their physician for other treatment recommendations. Improving one's diet is always a good idea as is exercising regularly to reduce stress. Heartburn generally occurs when "acid escape from the stomach into the esophagus. Common heartburn triggers are certain types of foods, the time you eat, and how fast you eat," according to Pepsid.com

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.